PENGUIN BIO
Live / Allowed — Third extension granted (statement of use) (as of 22 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Apr 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98514367
- Mark type
- Word mark
- Filed
- 23 Apr 2024
- Published for opposition
- 03 Dec 2024
- Attorney of record
- Aaron Y. Silverstein
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of metabolic diseases
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- PENGUIN BIO CORP., NEW YORK, NY, US
- Ghrelco, Inc., New York, NY, US
- Ghrelco, Inc., New York, NY, US
Prosecution history
- 22 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jun 2026 — SOU EXTENSION 3 GRANTED
- 22 Jun 2026 — SOU EXTENSION 3 FILED
- 22 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 2 GRANTED
- 12 Nov 2025 — SOU EXTENSION 2 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 08 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2025 — SOU EXTENSION 1 GRANTED
- 07 May 2025 — SOU EXTENSION 1 FILED
- 07 May 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED